Found 6 matching trials
Intraperitoneal Injection of Oncolytic Viruses H101 for Patients With Refractory Malignant Ascites PHASE2 Assessment of effectiveness, safety and local immune activation of Oncolyti...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Intra-tumor Injection of Oncolytic Viruses H101 Combined With or Without Radiotherapy in Refractory/Recurrent Gynecological Malignancies PHASE2 The purpose of this clinical trial is to evaluate the effectiveness and saf...
Show More Location
The First Affiliated Hospital of Xi'an Jiao Tong University
Learn More & Join Trial
Oncolytic Virotherapy Combined With Tislelizumab Plus Lenvatinib in Patients With Advanced Biliary Tract Cancer (OPTIONS-05) PHASE2 The objective of this study is to evaluate the efficacy and safety of oncol...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Oncorine (H101) Combined With Tislelizumab and Chemotherapy in Previously Untreated Advanced Non-small Cell Lung Cancer PHASE1 This is a single-arm, single-centre phase II study to evaluate the efficacy...
Show More Location
Fujian Cancer Hospital
Learn More & Join Trial
Oncolytic Virotherapy Plus PD-1 Inhibitor and Lenvatinib as Second-line or Later Therapy in Patients With Advanced Hepatocellular Carcinoma PHASE1 The objective of this study is to evaluate the safety/tolerability efficacy...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Systemic Chemotherapy Combined With Recombinant Human Adenovirus Type 5 and Endostatin Injections for Treatment Malignant Hydrothorax in NSCLC Patients PHASE3 The purpose of this multi-center clinical trial is to verify more effective...
Show More Location
Multiple Locations
Learn More & Join Trial